Regency Fincorp moves to reshape its capital structure
TL;DR
What is the post-issue paid-up equity share capital and the resulting percentage dilution for existing shareholders, accounting for the ₹72.05 Cr preferential issue and the proposed increase in authorized share capital?
Post-issue paid-up equity share capital would be approximately ₹103.12 Cr, with existing shareholders diluted by approximately 13.8%.
Calculation
- Current paid-up equity share capital: ₹88.85 Cr [1]
- Face value: ₹10 per share [2]
- Existing shares: ₹88.85 Cr ÷ ₹10 = 8.885 Cr shares
- Preferential equity issue: 1.4266412 Cr shares for ₹72.05 Cr [3]
- Post-issue shares: 8.885 Cr + 1.4266412 Cr = 10.3116412 Cr shares
- Post-issue paid-up capital: 10.3116412 Cr × ₹10 = ₹103.12 Cr
- Existing shareholders’ residual ownership: 8.885 ÷ 10.3116412 = 86.2%
- Dilution: 100% − 86.2% = 13.8%
The ₹72.05 Cr issue price should not be added in full to paid-up capital: only the ₹10 face-value component—₹14.27 Cr—raises paid-up capital; the balance is securities premium.
The authorized capital increase from ₹95 Cr to ₹152 Cr [3] does not itself cause dilution. It increases the maximum permitted equity capital to 15.2 Cr shares, while the post-issue paid-up capital would be ₹103.12 Cr, leaving authorized-capital headroom of approximately ₹48.88 Cr.
This calculation excludes the separately proposed conversion of 4.754603 Cr warrants and the ESOP pool, which would create additional potential dilution if exercised or allotted [4].
What is the issue price per share for the ₹72.05 Cr preferential allotment, and how does this price compare to the floor price calculated under SEBI (ICDR) Regulations, 2018, based on the relevant date?
The issue price was ₹50.50 per equity share, comprising a ₹10 face value and ₹40.50 premium. The allotment of 1,42,66,412 shares aggregated to ₹72,04,53,806, or approximately ₹72.05 Cr. [5]
The filing states that this price was calculated under Regulation 164 read with Regulation 166A of the SEBI (ICDR) Regulations, 2018, by a registered valuer. [5] However, the cited disclosure does not provide the relevant date or the separately calculated floor price. Therefore, the premium or discount of the ₹50.50 issue price to the regulatory floor price could not be confirmed from the available filing extract. The compliance statement alone does not establish that ₹50.50 was exactly equal to the floor price.
What is the total number of options proposed under the 'ESOP 2026 Scheme' as a percentage of the post-issue paid-up equity capital, and what is the estimated accounting impact on employee benefit expenses over the vesting period?
I couldn't find relevant information for this query. Please try rephrasing or asking about a specific metric.
Sources
- [1]Equity Share Capital
- [2]Face Value
- [3]Regency Fincorp: Approval of Authorized Capital Increase, Preferential Issue, and ESOP 2026 Scheme — 2026-11-11T16:37:57.230000, p.1
- [4]Regency Fincorp: Approval of Authorized Capital Increase, Preferential Issue, and ESOP 2026 Scheme — 2026-11-11T16:37:57.230000, p.2
- [5]Regency Fincorp: Approval of Authorized Capital Increase, Preferential Issue, and ESOP 2026 Scheme — 2026-11-11T16:37:57.230000, p.4
Keep digging
